Molecular Cancer

official impact factor 3.78

Open Access Highly Access

Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

Michael D Mattie*, Christopher C Benz, Jessica Bowers, Kelly Sensinger, Linda Wong, Gary K Scott, Vita Fedele, David Ginzinger, Robert Getts and Chris Haqq

Molecular Cancer 2006, 5:24 doi:10.1186/1476-4598-5-24

Accesses  

  • Last 30 days: 297 accesses
  • Last 365 days: 3418 accesses
  • All time: 20799 accesses

Cited by

BioMed Central: 22 citations

Review   Open Access

Recent updates on the role of microRNAs in prostate cancer

Oudai Hassan, Aamir Ahmad, Seema Sethi, Fazlul H Sarkar Journal of Hematology & Oncology 2012, 5:9 (14 March 2012)

Research   Open Access Highly Accessed

De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer

Xiwei Wu, George Somlo, Yang Yu, Melanie R Palomares, Arthur Li, Weiying Zhou, Amy Chow, Yun Yen, John J Rossi, Harry Gao, Jinhui Wang, Yate-Ching Yuan, Paul Frankel, Sierra Li, Kimlin Ashing-Giwa, Guihua Sun, Yafan Wang, Robin Smith, Kim Robinson, Xiubao Ren, Shizhen Wang Journal of Translational Medicine 2012, 10:42 (8 March 2012)

Review   Open Access

Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies

Angela Hui, Christine How, Emma Ito, Fei-Fei Liu BMC Cancer 2011, 11:500 (30 November 2011)

Research article   Open Access Highly Accessed

Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67

Shinichiro Kashiwagi, Masakazu Yashiro, Tsutomu Takashima, Naoki Aomatsu, Katsumi Ikeda, Yoshinari Ogawa, Tetsuro Ishikawa, Kosei Hirakawa Breast Cancer Research 2011, 13:R122 (30 November 2011)

Research article   Open Access

NMD and microRNA expression profiling of the HPCX1 locus reveal MAGEC1 as a candidate prostate cancer predisposition gene

Henna Mattila, Martin Schindler, Jarkko Isotalo, Tarja Ikonen, Mauno Vihinen, Hannu Oja, Teuvo LJ Tammela, Tiina Wahlfors, Johanna Schleutker BMC Cancer 2011, 11:327 (2 August 2011)

Research article   Open Access Highly Accessed

Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer

Carina Roth, Brigitte Rack, Volkmar Müller, Wolfgang Janni, Klaus Pantel, Heidi Schwarzenbach Breast Cancer Research 2010, 12:R90 (3 November 2010)

Research   Open Access Highly Accessed

Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients

Stefano Gambardella, Fabrizio Rinaldi, Saverio M Lepore, Antonella Viola, Emanuele Loro, Corrado Angelini, Lodovica Vergani, Giuseppe Novelli, Annalisa Botta Journal of Translational Medicine 2010, 8:48 (20 May 2010)

Review   Free Highly Accessed

MicroRNAs and their target gene networks in breast cancer

Elizabeth O'Day, Ashish Lal Breast Cancer Research 2010, 12:201 (19 March 2010)

Research article   Open Access

Characterisation of microRNA expression in post-natal mouse mammary gland development

Stefanie Avril-Sassen, Leonard D Goldstein, John Stingl, Cherie Blenkiron, John Le Quesne, Inmaculada Spiteri, Konstantina Karagavriilidou, Christine J Watson, Simon Tavaré, Eric A Miska, Carlos Caldas BMC Genomics 2009, 10:548 (20 November 2009)

Research   Open Access Highly Accessed

mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer

Chao Cheng, Xuping Fu, Pedro Alves, Mark Gerstein Genome Biology 2009, 10:R90 (1 September 2009)

Most microRNAs have a stronger inhibitory effect in estrogen receptor-negative than in estrogen receptor-positive breast cancers

Research article   Open Access Highly Accessed

MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of Type 2 Diabetes

Blanca M Herrera, Helen E Lockstone, Jennifer M Taylor, Quin F Wills, Pamela J Kaisaki, Amy Barrett, Carme Camps, Christina Fernandez, Jiannis Ragoussis, Dominique Gauguier, Mark I McCarthy, Cecilia M Lindgren BMC Medical Genomics 2009, 2:54 (18 August 2009)

Combining global microRNA and mRNA expression data indicates MiR-125a is over-expressed in the liver of hyperglycaemic rats and is a putative modulator of glucose and lipid metabolism in a rat model of type 2 diabetes.

Primary research   Open Access

Intrinsic expression of host genes and intronic miRNAs in prostate carcinoma cells

Kavleen Sikand, Stephen D Slane, Girish C Shukla Cancer Cell International 2009, 9:21 (12 August 2009)

Research article   Open Access Highly Accessed

MicroRNA expression profiling of male breast cancer

Matteo Fassan, Raffaele Baffa, Juan P Palazzo, Joshua Lloyd, Marco Crosariol, Chang-Gong Liu, Stefano Volinia, Hannes Alder, Massimo Rugge, Carlo M Croce, Anne Rosenberg Breast Cancer Research 2009, 11:R58 (10 August 2009)

Research   Open Access

Down-regulated miR-9 and miR-433 in human gastric carcinoma

Hongchun Luo, Hongbin Zhang, Zhenzhen Zhang, Xia Zhang, Bo Ning, Jinjun Guo, Na Nie, Bo Liu, Xiaoling Wu Journal of Experimental & Clinical Cancer Research 2009, 28:82 (16 June 2009)

Research article   Open Access Highly Accessed

MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer

Aoife J Lowery, Nicola Miller, Amanda Devaney, Roisin E McNeill, Pamela A Davoren, Christophe Lemetre, Vladimir Benes, Sabine Schmidt, Jonathon Blake, Graham Ball, Michael J Kerin Breast Cancer Research 2009, 11:R27 (11 May 2009)

Research article   Open Access Highly Accessed

Identification and characterization of new miRNAs cloned from normal mouse mammary gland

Nezha Sdassi, Licia Silveri, Johann Laubier, Gaëlle Tilly, José Costa, Sarah Layani, Jean-Luc Vilotte, Fabienne Le Provost BMC Genomics 2009, 10:149 (7 April 2009)

Research   Open Access Highly Accessed

Molecular assays for the detection of microRNAs in prostate cancer

Amara C Siva, Luke J Nelson, Chad L Fleischer, Mehrdad Majlessi, Michael M Becker, Robert L Vessella, Mark A Reynolds Molecular Cancer 2009, 8:17 (6 March 2009)

Research article   Open Access Highly Accessed

Global gene expression analysis reveals reduced abundance of putative microRNA targets in human prostate tumours

Ruping Sun, Xuping Fu, Yao Li, Yi Xie, Yumin Mao BMC Genomics 2009, 10:93 (26 February 2009)

Research article   Open Access Highly Accessed

Measuring microRNAs: Comparisons of microarray and quantitative PCR measurements, and of different total RNA prep methods

Robert A Ach, Hui Wang, Bo Curry BMC Biotechnology 2008, 8:69 (11 September 2008)

Methodology article   Open Access Highly Accessed

Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer

Pamela A Davoren, Roisin E McNeill, Aoife J Lowery, Michael J Kerin, Nicola Miller BMC Molecular Biology 2008, 9:76 (21 August 2008)

Research article   Open Access Highly Accessed

PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes

Anna Git, Inmaculada Spiteri, Cherie Blenkiron, Mark J Dunning, Jessica CM Pole, Suet-Feung Chin, Yanzhong Wang, James Smith, Frederick J Livesey, Carlos Caldas Breast Cancer Research 2008, 10:R54 (27 June 2008)

Breast cancer cell line PMC42 is a good model for normal breast epithelium, providing a unique biological tool to study breast differentiation and the function of key miRNAs typically lost in cancer.

Research   Open Access Highly Accessed

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

Cherie Blenkiron, Leonard D Goldstein, Natalie P Thorne, Inmaculada Spiteri, Suet-Feung Chin, Mark J Dunning, Nuno L Barbosa-Morais, Andrew E Teschendorff, Andrew R Green, Ian O Ellis, Simon Tavaré, Carlos Caldas, Eric A Miska Genome Biology 2007, 8:R214 (8 October 2007)

Integrated analysis of miRNA expression and genomic changes in human breast tumors allows the classification of tumor subtypes.